EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer

Fitran Amansyah, Prihantono Prihantono, Firdaus Hamid, Salman Ardi Syamsu, John Pieter, Muhammad Faruk

Breast Disease · 2024

DOI: 10.3233/bd-249000 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Breast Disease, 2024. Verfasst von Fitran Amansyah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia. Hauptthemen laut MEDLINE: Breast Neoplasms, Progression-Free Survival. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Molecular subtyping of breast cancer cells is increasingly being developed as an initial step in selecting therapy and predicting the prognosis of breast cancer patients. During breast cancer, the molecular subtype of cancer cells can change. This study aimed to analyze the relationship between changes in the intrinsic subtype of breast cancer with metastasis and progression-free survival in breast cancer patients. METHODS: This was a retrospective cohort study of patients diagnosed with breast cancer from 2016 to 2021. The molecular subtypes from the immunohistochemical examination results were recorded twice, and metastasis and progression-free survival (PFS) were recorded. The data were analyzed using the chi-square test and SPSS 26. RESULTS: Of the 44 patients, 19 (43.2%) experienced a change in molecular subtype, and 25 (56.8%) did not. No significant relationship existed between changes in molecular subtype and metastasis (p = 0.405). No significant relationship existed between changes in molecular subtype and PFS (p = 0.900). A significant relationship was found between changes in the molecular subtype and PFS in the patients with changes in the molecular subtype (p = 0.022). CONCLUSIONS: Changes in the intrinsic subtype were associated with PFS in breast cancer patients. Patients with an intrinsic subtype that changed to triple-negative showed worse PFS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsProgression-Free SurvivalHumansFemaleRetrospective StudiesMiddle AgedAdultAgedNeoplasm MetastasisPrognosisBiomarkers, TumorErb-b2 Receptor Tyrosine KinasesTriple Negative Breast Neoplasms

Stichwörter der Autor:innen

Breast cancermetastasismolecular subtypeprogression-free survival

Substanzen

Biomarkers, TumorErb-b2 Receptor Tyrosine Kinases

Autor:innen und Institutionen

  • Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
  • Department of Clinical Microbiology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.
  • Division of Oncology, Department of Surgery, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia.

Zitieren

APA

Amansyah, F., Prihantono, P., Hamid, F., Syamsu, S. A., Pieter, J., & Faruk, M. (2024). The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer. Breast Disease. https://doi.org/10.3233/bd-249000

Vancouver

Amansyah F, Prihantono P, Hamid F, Syamsu SA, Pieter J, Faruk M. The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer. Breast Disease. 2024. doi:10.3233/bd-249000

BibTeX
@article{Amansyah2024,
  author = {Amansyah, Fitran and Prihantono, Prihantono and Hamid, Firdaus and Syamsu, Salman Ardi and Pieter, John and Faruk, Muhammad},
  title = {The relationship of changes in molecular subtypes with metastases and progression-free survival in breast cancer},
  journal = {Breast Disease},
  year = {2024},
  doi = {10.3233/bd-249000}
}
Kostenlos starten →